Maxcyte (MXCT) FCF Margin Growth (3y) (2023 - 2026)
Maxcyte (MXCT) FCF Margin Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.52 Bn | 193.92 Bn | 7.27 Bn | 884.00 |
| 2 | Stryker | 129.55 Bn | 126.07 Bn | 4.50 Bn | 534.00 |
| 3 | Medtronic | 119.60 Bn | 110.38 Bn | 6.41 Bn | -310.00 |
| 4 | Boston Scientific | 73.64 Bn | 73.10 Bn | 3.85 Bn | 919.00 |
| 5 | Edwards Lifesciences | 52.33 Bn | 48.08 Bn | 1.35 Bn | 3,472.00 |
| 6 | Dexcom | 34.69 Bn | 32.74 Bn | 830.00 Mn | -97.00 |
| 7 | GE HealthCare Technologies | 34.10 Bn | 31.99 Bn | 2.18 Bn | 413.00 |
| 8 | Koninklijke Philips | 26.43 Bn | 23.11 Bn | 4.55 Bn | -63.00 |
| 9 | Steris | 23.23 Bn | 22.75 Bn | 684.20 Mn | 60.00 |
| 10 | Maxcyte | 147.95 Mn | 147.95 Mn | 5.60 Mn | 7,492.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 7,492.00 |
| Mar 31, 2026 | -8,327.00 |
| Dec 31, 2025 | 35,763.00 |
| Sep 30, 2025 | -4,646.00 |
| Jun 30, 2025 | -18,840.00 |
| Mar 31, 2025 | -6,133.00 |
| Dec 31, 2024 | -10,244.00 |
| Sep 30, 2024 | -3,615.00 |
| Jun 30, 2024 | -1,514.00 |
| Mar 31, 2024 | -7,792.00 |
| Dec 31, 2023 | 1,730.00 |
| Sep 30, 2023 | -21,800.00 |